000 01711 a2200517 4500
005 20250513161316.0
264 0 _c19990514
008 199905s 0 0 eng d
022 _a0017-5749
024 7 _a10.1136/gut.44.2.212
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWarny, M
245 0 0 _aBovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.
_h[electronic resource]
260 _bGut
_cFeb 1999
300 _a212-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bacterial
_xmetabolism
650 0 4 _aAntitoxins
_xmetabolism
650 0 4 _aBacterial Toxins
_ximmunology
650 0 4 _aCattle
650 0 4 _aClostridioides difficile
_ximmunology
650 0 4 _aColostrum
_ximmunology
650 0 4 _aDigestive System
_xmetabolism
650 0 4 _aEnterotoxins
_ximmunology
650 0 4 _aFemale
650 0 4 _aGastric Mucosa
_xmetabolism
650 0 4 _aGastrointestinal Transit
650 0 4 _aHumans
650 0 4 _aIleum
_xmetabolism
650 0 4 _aImmunoglobulin G
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aFatimi, A
700 1 _aBostwick, E F
700 1 _aLaine, D C
700 1 _aLebel, F
700 1 _aLaMont, J T
700 1 _aPothoulakis, C
700 1 _aKelly, C P
773 0 _tGut
_gvol. 44
_gno. 2
_gp. 212-7
856 4 0 _uhttps://doi.org/10.1136/gut.44.2.212
_zAvailable from publisher's website
999 _c9857123
_d9857123